Patient and Provider Perspectives on a Decision Aid for Familial Hypercholesterolemia
- PMID: 30400379
- PMCID: PMC6313606
- DOI: 10.3390/jpm8040035
Patient and Provider Perspectives on a Decision Aid for Familial Hypercholesterolemia
Abstract
Familial Hypercholesterolemia (FH) is an inherited disorder associated with increased cardiovascular risk that requires patients to make multiple impactful decisions regarding the management of their condition. Patient decision aids (PDAs) can facilitate shared decision-making (SDM) and enable patients to make choices that are concordant with their goals and values. To inform the development of a PDA for patients with FH, we employed a qualitative inductive approach and focus group discussions with patients, physicians, and genetic counselors. We explored and analyzed the perceptions and understanding of these stakeholders related to a PDA for FH and identified important concepts to include in the PDA. Categories emerging from focus group discussions included: (a) perceptions of a PDA related to FH; (b) discussion about the content of a PDA related to FH; and (c) SDM. In general, stakeholders were in favor of developing tools which can inform and individualize discussion about genetic testing and treatment options for FH. Physicians valued a tool that facilitates knowledge transfer to FH patients. Patients desired a tool to help them understand the genetic aspects of and treatment options related to FH. Genetic counselors emphasized the inclusion of visual aids to support discussion with patients. Potential barriers to and facilitators of PDA implementation were identified. The input of various stakeholders will inform the development of a prototype tool that will be iteratively tested before implementation in the clinical setting.
Keywords: familial hypercholesterolemia; focus group discussions; patient decision aid; shared decision-making.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Abul-Husn N.S., Manickam K., Jones L.K., Wright E.A., Hartzel D.N., Gonzaga-Jauregui C., O’Dushlaine C., Leader J.B., Lester Kirchner H., Lindbuchler D.M., et al. Genetic identification of familial hypercholesterolemia within a single U.S. health care system. Science. 2016;354 doi: 10.1126/science.aaf7000. - DOI - PubMed
-
- Nordestgaard B.G., Chapman M.J., Humphries S.E., Ginsberg H.N., Masana L., Descamps O.S., Wiklund O., Hegele R.A., Raal F.J., Defesche J.C. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus statement of the European Atherosclerosis Society. Eur. Heart J. 2013;34:3478–3490. doi: 10.1093/eurheartj/eht273. - DOI - PMC - PubMed
-
- Huijgen R., Hutten B.A., Kindt I., Vissers M.N., Kastelein J.J.P. Discriminative ability of LDL-cholesterol to identify patients with familial hypercholesterolemia: a cross-sectional study in 26,406 individuals tested for genetic FH. Circ. Cardiovasc. Genet. 2012;5:354–359. doi: 10.1161/CIRCGENETICS.111.962456. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous